Intensity of end‐of‐life care for patients with myelodysplastic syndromes: Findings from a large national database

Abstract

The intensity of EOL care for patients with MDS varies but is potentially suboptimal with respect to the traditional measure of hospice use. The lower odds of enrollment for transfusion-dependent patients suggest that the current hospice model, which largely disallows transfusions, may not be meeting the palliative needs of this population.